Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales Montero, F., Lo, K., . . . Tabrizi, S. J. (2019). MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1.
Chicago Style aipamenaFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
MLA aipamenaFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.